Health IT – Pushing Healthcare to the Edge

Healthcare represents over 17 percent of U.S. GDP, yet continues to remain one of the areas where technology has not had a deflationary effect on the costs to deliver the service. We’re excited about expanding our portfolio in this area as health IT is certainly an approachable and investible domain for a Seed fund. Yet we … Read more

Bee Partners’ Portfolio Companies Defined 2020 with Remarkable Resilience, Innovation and Growth

Stunning, unprecedented, chaotic…relentless.  At some point, each of us at Bee Partners used those–and many other colorful–words to make sense of 2020. But, we also tested our ability to pivot quickly and effectively in order to provide the support our portfolio companies needed as we all adapted to our new reality. Perhaps surprisingly, 2020 brought a … Read more

Bee Partners Adds Product & Startup Expert Alejandra Vergara as Associate

San Francisco and Denver – September 8, 2022 – Continuing its unconventional approach to team building, Bee Partners recently hired Ale Vergara as an Associate.  Michael Berolzheimer, Founder & Managing Partner commented, “We underwrite every company in our portfolio to return the fund… to achieve such discipline we need associates who’ve experienced breadth as both … Read more

Congratulations, SugarCRM, on the Acquisition of Node.io

Big congratulations to the smart thinkers at SugarCRM who have picked up Node.io. You can read the news in TechCrunch. Node’s AI-as-a-service platform augments sales, marketing, and human resources teams with machine learning-powered customer predictions and lead recommendations, enabling users to connect with better sales leads and potential customers. That’s right in SugarCRM’s sweet spot … Read more

Addressing Deeptech’s Challenges Now

Deeptech’s scientific and tech-innovation demands bring unique challenges for early-stage companies and their investors. Bee Partners has a long-standing interest in deeptech. We all four have a little science geek in us and we’ve witnessed through our investments the world-changing power of deeply researched and singularly applied solutions that only deeptech can provide.   Our deeptech … Read more

Good Governance Pays Dividends

In the summer of 2015, we discussed the commitment to good governance that we uphold at Bee Partners. Our philosophy is essentially that there’s so much uncertainty in a startup, that reducing any governance risk early in a company’s lifecycle only pays dividends moving forward. And while this practice is often found on the “important, not urgent” … Read more

Why D&I Matters and What We’re Doing

It seems like a straight-forward question: “As an entrepreneur, if I experience harassment or discrimination, where do I report it and how will I be protected?” Emotional safety is something we value highly at Bee Partners. How can Founders, who risk so much already, possibly function without it? Yet so many cannot be certain they … Read more

My Internship at Bee Partners, a Sandbox for Founders

By Santiago Freyria By Santiago Freyria, Haas 2020 Six years ago I was an undergrad in economics looking for a part-time job. After more than 50 rejections because of lack of experience, I was willing to work for free. It turned out to be the best thing that has happened in my career, as I … Read more

Announcing Bee Partners III: $43M to Invest and a New Partner

It is with profound gratitude and a sense of great purpose that Garrett, Tim, Kira and I officially announce today the closing of our $43M fund, Bee Partners III.  You may have already learned this news from our own personal conversations these last few months or today from VC Journal and Crunchbase News. And as … Read more

Synthetic Biology

Building Technology at the Genetic Level Executive Summary  Our ability to design and engineer biological components and systems at the genetic level has increased substantially over the previous decade. In 2010, the first self-replicating cell was created from artificial DNA, which was built by researchers out of chemically synthesized oligonucleotides. Since then, the cost per … Read more